Health IT

iPhone or Android: Which is better for doctors? (Morning Read)

Highlights of the important and the interesting from the world of healthcare: iPhone or Android: Which is better for doctors? The answer, according to Jeff Brandt, president of Communication Software, appears to be “both.” While that may be a bit unsatisfying, Brandt says that the Android–since it’s an operating system used in numerous types of […]

Highlights of the important and the interesting from the world of healthcare:

iPhone or Android: Which is better for doctors? The answer, according to Jeff Brandt, president of Communication Software, appears to be “both.” While that may be a bit unsatisfying, Brandt says that the Android–since it’s an operating system used in numerous types of phones, rather than just one type of phone–offers greater flexibility. And you’re not stuck with AT&T.

Governor VC: Exconomy has the background on Rick Snyder, an entrepreneur and venture capitalist who won the Republican primary in Michigan’s gubernatorial race.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Uh oh, EHRs: Huffington Post is back with the latest installment of its look at the federal government’s push into electronic health records–and the potential patient-safety concerns associated with it. “That no process exists to report and track errors, pinpoint their causes and prevent them from recurring is largely the result of two decades of resistance by the technology industry.”

Too many layoffs: Healthcare is still a great industry to be in (if you want to  remain employed), but it’s still feeling lots of economic pain, like pretty much all other industries. Pharmaceutical firms cut more than 2,000 jobs in July, while several hospitals engaged in mass layoffs, too.

Pull that patent: Patients with a rare genetic disease who are depedent on a Genzyme drug called Fabrazyme are asking the federal goverment to  invalidate the company’s patent. The drug isn’t widely enough available due to manufacturing problems at Genzyme. Such petitions for the government to exercise its “march-in rights” have been filed before, but have never succeeded.

Photo from flickr user Yutaka Tsutano